Tag : Milestones

Neurology

Ataluren Delays Disease Milestones in Nonsense Mutation DMD

Newsemia
Long-term treatment with ataluren delays loss of ambulation and may delay decline in pulmonary function in patients with nonsense mutation Duchenne muscular dystrophy (nmDMD), according...
Latest News

Symproic Insight Report, 2019: Drug Overview, Mechanism of Action, Clinical Trials, Regulatory Milestones, Deals, Partnerships, and Sales Forecasting to 2021 – ResearchAndMarkets.com

Newsemia
DUBLIN–(BUSINESS WIRE)–The “Symproic – Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s offering. Symproic – Drug Insight, 2019 report provides comprehensive information of the...
Latest News

Balversa Drug Insight Report, 2019: Drug Overview, Mechanism of Action, Clinical Trials, Regulatory Milestones, Deals, Partnerships, and Sales Forecasting to 2021 – ResearchAndMarkets.com

Newsemia
DUBLIN–(BUSINESS WIRE)–The “Balversa – Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s offering. Balversa – Drug Insight, 2019 report provides comprehensive information of the...
Latest News

Tremfya Drug Insight Report, 2019: Drug Overview, Mechanism of Action, Clinical Trials, Regulatory Milestones, Deals, Partnerships, and Sales Forecasting to 2021 – ResearchAndMarkets.com

Newsemia
DUBLIN–(BUSINESS WIRE)–The “Tremfya – Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s offering. Tremfya – Drug Insight, 2019 report provides comprehensive information of the...
Latest News

Nerlynx Drug Insight Report, 2019: Drug Overview, Mechanism of Action, Clinical Trials, Regulatory Milestones, Deals, Partnerships, and Sales Forecasting to 2021 – ResearchAndMarkets.com

Newsemia
DUBLIN–(BUSINESS WIRE)–The “Nerlynx – Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s offering. Nerlynx – Drug Insight, 2019 report provides comprehensive information of the...
Latest News

Galafold Drug Insight Report, 2019: Drug Overview, Mechanism of Action, Clinical Trials, Regulatory Milestones, Deals, Partnerships, and Sales Forecasting to 2021 – ResearchAndMarkets.com

Newsemia
DUBLIN–(BUSINESS WIRE)–The “Galafold – Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s offering. Galafold – Drug Insight, 2019 report provides comprehensive information of the...
Latest News

Erleada Drug Insight Report, 2019: Drug Overview, Mechanism of Action, Clinical Trials, Regulatory Milestones, Deals, Partnerships, and Sales Forecasting to 2021 – ResearchAndMarkets.com

Newsemia
DUBLIN–(BUSINESS WIRE)–The “Erleada – Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s offering. Erleada – Drug Insight, 2019 report provides comprehensive information of the...
Latest News

Radicava Drug Insight Report, 2019: Drug Overview, Mechanism of Action, Clinical Trials, Regulatory Milestones, Deals, Partnerships, and Sales Forecasting to 2021 – ResearchAndMarkets.com

Newsemia
DUBLIN–(BUSINESS WIRE)–The “Radicava – Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s offering. Radicava – Drug Insight, 2019 report provides comprehensive information of the...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy